This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://dx.doi.org/10.1177/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50480530
rdf:type
wikibase:Item
schema:description
vedecký článok tieteellinen artikkeli scientific article published in April 2006 artículo científico publicado en 2006 научни чланак სამეცნიერო სტატია article scientifique 2006年學術文章 artigo científico مقالة علمية نشرت في أبريل 2006 vitskapeleg artikkel наукова стаття, опублікована у квітні 2006 2006年學術文章 επιστημονικό άρθρο מאמר מדעי scientific article published in April 2006 2006년 논문 bilimsel makale научна статия 2006 nî lūn-bûn artikull shkencor articolo scientifico scientific article published in April 2006 এপ্রিল ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vědecký článek мақолаи илмӣ artigo científico artykuł naukowy vitenskapelig artikkel 2006年学术文章 artigo científico naučni članak article scientific 2006年学术文章 artikel ilmiah vetenskaplig artikel 2006年學術文章 article científic artículu científicu wetenschappelijk artikel научни чланак scienca artikolo 2006年學術文章 articol științific wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ 2006年学术文章 2006年学术文章 bài báo khoa học teaduslik artikkel 2006年学术文章 2006年學術文章 2006年の論文 научная статья artikulong pang-agham videnskabelig artikel tudományos cikk 2006年学术文章
p:P577
wds:Q50480530-62BF2056-5EA0-4C61-A721-BEAB115A002C
wdt:P577
2006-04-01T00:00:00Z
p:P2860
wds:Q50480530-019B3E7B-27D3-40D0-8B5A-04DCCE0D0193 wds:Q50480530-9693E88C-0DEE-45F4-B192-615C75C73CFD wds:Q50480530-988EBD58-52BB-438D-8E45-AD5E335A9B70 wds:Q50480530-BDB80685-954C-4BCE-BDFA-A5E9FD0BDD46 wds:Q50480530-4B0FEDFB-B0E3-4F1B-B242-E0D729E56A06 wds:Q50480530-FFFFD61A-D6B8-4F37-AF93-2C886B7DE78C wds:Q50480530-C3B7BEEB-F7C4-4F63-9FEB-3F4853C30AAD wds:Q50480530-DB2AC41B-F260-45D2-AFB3-65F56BC93AB3 wds:Q50480530-E9FA1352-CE82-45F6-90D9-6E3C68980182 wds:Q50480530-FFF90E08-0F66-4DFF-B4C1-7A29A13F186B
wdt:P2860
wd:Q46644799 wd:Q36065525 wd:Q44471704 wd:Q35858344 wd:Q30873528 wd:Q34983298 wd:Q44686656 wd:Q44508651 wd:Q40548802 wd:Q35097977
p:P2093
wds:Q50480530-F4E9B0F5-4070-458B-A57A-744647AC88AE wds:Q50480530-70A7774E-A9C2-4DE7-8372-33399B96DBC7 wds:Q50480530-8417E65F-4332-406F-9BD2-96F072CC0843 wds:Q50480530-495DE9B0-EB44-4AAE-BBE1-1ACA90FA955C wds:Q50480530-40977BBF-3D59-4C56-8507-F72E72A7D072 wds:Q50480530-48328290-7B74-4063-9C77-C53C5901F5F2 wds:Q50480530-3FAD13C0-6F5C-4E3C-B052-88DC1B71D031
wdt:P2093
Nicholson S Klem B de Vries DE van de Wetering J Lappin G Oosterhuis B Garner RC
rdfs:label
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers. Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.
skos:prefLabel
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers. Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.
schema:name
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers. Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.
p:P1476
wds:Q50480530-9F45EF5A-7667-4763-863A-3228BBAFC98B
wdt:P1476
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.
p:P304
wds:Q50480530-84C9AD78-545B-478E-B55F-214BF16AC59A
wdt:P304
456-460
p:P31
wds:Q50480530-DA4A179A-28B6-44C4-B9F8-03EEFFBCDA5A
wdt:P31
wd:Q13442814
p:P921
wds:Q50480530-59CDFE9A-C493-49CA-8662-A252BDF755E1
wdt:P921
wd:Q461809
p:P698
wds:Q50480530-FA3BB647-5E0B-4622-8E0B-014AEDF3E60B
wdtn:P698
n12:16554454
wdt:P698
16554454
p:P1433
wds:Q50480530-628E2677-74A5-4787-B5C3-1FBAD966BD08
wdt:P1433
wd:Q7743562
p:P433
wds:Q50480530-8D87445F-573C-492C-98D1-17E3866F8660
p:P478
wds:Q50480530-F095399C-9E64-4B0A-9380-ED70A7E56B27
wdt:P433
4
wdt:P478
46
p:P356
wds:Q50480530-2400A890-9D6C-4DCA-904A-9BB86C1A11E1
wdtn:P356
n6:0091270006286849
wdt:P356
10.1177/0091270006286849
p:P8608
wds:Q50480530-4D89F440-FE49-40BA-8C17-9C8D3B1D9B07
wdt:P8608
release_eh3lqbqv7zf2xp4js7g6g2paru